跳至主要内容
临床试验/NCT02465476
NCT02465476已完成不适用

Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine

University Hospital, Toulouse2 个研究点 分布在 1 个国家目标入组 212 人开始时间: 2015年1月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
212
试验地点
2
主要终点
Number of hospital visits

研究概览

简要总结

The investigators want to demonstrate that a new organization with telemedicine could rationalize the treatment pathway of patient suffering from rare skin disease. A diagnosis and a personalised treatment pathway could be performed before the consultation in the hospital.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • New patients suffering from a rare skin disease whatever pathology or age, which needs a take-over by this centre
  • Or patients already take-over by the centre but lost to follow-up for more than one year
  • Patients (and/or parents) who give their consents
  • Patients (and/or parents) able to fill in questionnaires

排除标准

  • Pregnant or breast-feeding women.
  • Patients subject to a judicial safeguard order
  • Patients who need an emergency take-over
  • Patients followed by a doctor who does not have a computerized system or refuse to send data via the secured messaging

研究组 & 干预措施

normal care

No Intervention

patient who will have normal treatment pathway

telemedicine

Experimental

patient who will have telemedicine

干预措施: telemedicine (Procedure)

结局指标

主要结局

Number of hospital visits

时间窗: 6 months

Interest of a procedure of telemedicine on the organization of the treatment pathway of patients affected by rare skin diseases in terms of change of the number of visit in hospital.

次要结局

  • Improvement of the treatment pathway and its organization(6 months)
  • Change of the cost related to the patient care (direct and indirect).(6 months)
  • management of time by the medical personal.(6 months)
  • Satisfaction of the patient(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Rationalization of the Treatment Pathway of Patient... | 临床试验